It's not all about CRISPR – Calyxt demonstrates how TALENs are still a highly valuable approach to bringing genome editing to consumers

May 22, 2018 | Case Study

Calyxt, formerly the plant sciences department of gene editing giant Cellectis, is working to be a leader in providing value-added ingredients to the food industry, derived from crops developed with genome editing. While much of the industry is swept up in the desire to use and refine CRISPR tools, Calyxt has quietly and methodically continued using TALENs, an older but still highly capable approach to editing crop genomes.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978